Slower Spread of Clubroot in Saskatchewan in 2021

Jan 12, 2022

There was a slower pace of clubroot spread across Saskatchewan this past year.

Released Monday, the latest annual Saskatchewan clubroot Distribution Map showed that visible symptoms of the disease have now been confirmed in 80 commercial canola fields since 2017, an increase of just five fields from the previous year. In 2020, the number of fields showing visible symptoms jumped by 24 from a year earlier.

Meanwhile, the number of fields where clubroot pathogen DNA was detected in soil samples (but with no visible symptoms) increased by nine in 2021, for a total of 38 fields in the province. In 2020, the number of affected fields without symptoms climbed by 18.

"The Ministry of Agriculture is dedicated to early detection, tracking and managing clubroot," Agriculture Minister David Marit said. "This protects our producers, landowners and our strong canola market."

Clubroot is a pest under provincial legislation and can cause major yield loss if left unmanaged. The disease produces club-like galls at canola roots.

Over 750 fields in 200 rural municipalities in Saskatchewan were examined during the province’s 2021 clubroot survey. The landowners of all fields with visible clubroot symptoms or fields with the presence of the pathogen DNA have been contacted. The locations of these fields have also been shared with the appropriate municipal office if they have enacted a clubroot-specific bylaw and visible symptoms were present.

Click here to see more...

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.